This Article  • PDF of this Correction  • Original article  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Arch Ophthalmol. 2000;118:488.

In the Clinical Sciences article by the Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group titled "Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin: One-Year Results of 2 Randomized Clinical Trials—TAP Report 1," published in the October issue of the ARCHIVES (1999;117:1329-1345), journal omission of financial disclosure, properly reported at the time of manuscript submission, occurred in the acknowledgment section on page 1344. The following statement should have appeared in this article: "Drs Sickenberg and Bressler are consultants for CIBA Vision Inc, Duluth, Ga, and QLT Phototherapeutics Inc, Vancouver, British, Columbia." The journal regrets the error.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findings
Stanga et al.
Br. J. Ophthalmol. 2003;87:975-976.
ABSTRACT | FULL TEXT